Skip to content

SCHEDULE 13GAccepted Oct 1, 4:05 PM ET

Spyre Therapeutics, Inc. SCHEDULE 13G

SYRESpyre Therapeutics, Inc.

Accepted (ET)

4:05 PM

Oct 1, 2026

Filed

Oct 1, 2026

Documents

2

Size

16.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.